Best in Biotech 13 Jun 2024 Eight companies tackling cancer with allogeneic cell therapy in 2024 Unlike autologous cell therapy, where the patient’s own cells are used, allogeneic cell therapy companies leverage donor cells, which can come from various sources such as bone marrow or umbilical cord blood. In allogeneic cell therapy, healthy donor cells are harvested, processed, and then infused into the patient. These donor cells can differentiate into various […] June 13, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 10 Jun 2024 ASCO 2024: The latest advances in oncology clinical trials Biotechs from all over the country as well as other parts of the world showcased recent pipeline advancements in oncology clinical trials at ASCO 2024. June 10, 2024 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 6 Jun 2024 CRISPR: A promising path to treating blindness Rigorous research, which has been going on for more than a decade now, suggests that CRISPR could treat genetic diseases including blindness. June 6, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 May 2024 8 Swedish companies spearheading the country’s biotech scene As Sweden’s life sciences sector continues to grow, we explore 8 biotech companies in Sweden that are leading the way in the industry. May 28, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Podcast 24 May 2024How biotech is tackling myasthenia gravis To talk about the disease, how it is being treated, and what is in the pipeline for future treatments, we had a conversation with Dana Vigier, head of Central Eastern and Northern Europe at Alexion. May 24, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 23 May 2024 Is prime editing ready for prime time? Prime editing, a more advanced version of CRISPR/Cas9 technology, has been greenlit by the FDA to begin the first-ever clinical trial for this technology. May 23, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 22 May 2024 The undruggable cancer target: KRAS inhibitors move ahead in the clinic Uncover the promise of KRAS inhibitors in cancer treatment, as evidenced by a $200 million investment in BridgeBio’s spinout. May 22, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Expert Advice 16 May 2024 Types of clinical trial designs: The essentials The average journey of a drug from trial to market is 10.5 years. Delve into the different clinical trials designs and their specificities. May 16, 2024 - 14 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 15 May 2024 Drugs for IgA nephropathy on the rise in the clinic As we observed IgA Nephropathy Awareness Day on May 14th, let us take a look at ongoing clinical trials for drugs that aim to make patient lives better. May 15, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 9 May 2024 BTK inhibitors: can these drugs tackle cancer and autoimmunity? BTK inhibitors were first approved over a decade ago to treat a rare blood cancer. Now, they are in the running to treat a host of autoimmune diseases. May 9, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 8 May 2024 New treatment for pulmonary hypertension: what biotech holds in store? While it has been about managing pulmonary hypertension’s symptoms for a long time, new treatments are adressing the root of the disease. May 8, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 6 May 2024 The rise of Spain: A key player in global clinical trials Spain has climbed the research and development ladder in recent years, and has made it to the top as one of the world leaders in the life science industry. May 6, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email